Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study
Open accessPublished version of a preprint
Abstract
Background: Major Depressive Disorder (MDD) is prevalent, often chronic, and requires ongoing monitoring of symptoms to track response to treatment and identify early indicators of relapse. Remote Measurement Technologies (RMT) provide an opportunity to transform the measurement and management of MDD, via data collected from inbuilt smartphone sensors and wearable devices alongside app-based questionnaires and tasks. A key question for the field is the extent to which participants can adhere to research protocols and the completeness of data collected. We aimed to describe drop out and data completeness in a naturalistic multimodal longitudinal RMT study, in people with a history of recurrent MDD. We further aimed to determine whether those experiencing a depressive relapse at baseline contributed less complete data. Methods: Remote Assessment of Disease and Relapse – Major Depressive Disorder (RADAR-MDD) is a multi-centre, prospective observational cohort study conducted as part of the Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) program. People with a history of MDD were provided with a wrist-worn wearable device, and smartphone apps designed to: a) collect data from smartphone sensors; and b) deliver questionnaires, speech tasks, and cognitive assessments. Participants were followed-up for a minimum of 11 months and maximum of 24 months. Results: Individuals with a history of MDD ( n = 623) were enrolled in the study,. We report 80% completion rates for primary outcome assessments across all follow-up timepoints. 79.8% of people participated for the maximum amount of time available and 20.2% withdrew prematurely. We found no evidence of an association between the severity of depression symptoms at baseline and the availability of data. In total, 110 participants had > 50% data available across all data types. Conclusions: RADAR-MDD is the largest multimodal RMT study in the field of mental health. Here, we have shown that collecting RMT data from a clinical population is feasible. We found comparable levels of data availability in active and passive forms of data collection, demonstrating that both are feasible in this patient group.
AI snapshot
Written from the paper’s full text.
TL;DR
RADAR-MDD enrolled 623 people with recurrent major depressive disorder across three sites and followed them for 11–24 months using smartphone and wearable remote measurement technologies. The study reports high retention and outcome completion (~80%) and comparable active/passive data availability, with no convincing evidence that baseline depression symptom severity predicts data availability.
Key findings
- Of 623 enrolled participants, 497 (79.8%) participated for the maximum possible duration and 126 (20.2%) withdrew prematurely; completion of primary and secondary outcomes was approximately 80% across follow-up, with 445 (71.4%) providing 1-year outcome data and 181 (29.1%) participating for a full 2 years.
- Median study participation was 541 days (IQR 401–730); 2.9 terabytes of compressed data were collected, and 110 participants (17.7%) had >50% available data across all modes of data collection.
- Active RMT: participants completed median 21 PHQ-8 questionnaires, 20 RSES questionnaires, and 12 speech tasks; any data were available for 95.3% (PHQ8), 94.5% (RSES), and 82.2% (speech). THINC-it tasks had median 5 completions each, with >84% of participants having any data for each test.
- Wearable RMT: average Fitbit wear-time was 62.5% (SD 9.1 percentage points) and mean 15.1 h/day; step count was most available (~50% provided >75% expected data), while activity data were least available (only 5% had >75%). Activity availability differed by baseline depression status (X² = 14.1, p = 0.002); passive smartphone data showed no evidence of difference by baseline depression in the narrative.
Methods
- Multi-centre, prospective observational cohort study (RADAR-MDD) within RADAR-CNS; 623 adults with recurrent MDD (DSM-5 non-psychotic MDD within past 2 years and ≥2 lifetime episodes) were recruited at King’s College London (UK), Amsterdam University Medical Centre (Netherlands), and CIBER (Barcelona, Spain), with follow-up of 11–24 months.
- Participants used a wrist-worn Fitbit Charge 2/3, RADAR-base active and passive smartphone apps (questionnaires, speech tasks, ESM, smartphone sensors), a THINC-it cognitive app, and REDCap outcome surveys every 3 months.
- Analyses described baseline characteristics; compared baseline symptomatic vs no/some depression symptoms using chi-squared tests, linear regressions, and t-tests for ESM; summarised data availability in quartiles; estimated Fitbit wear time from heart-rate values >0 per 15-min window; used STATA v16.0.
Limitations
- Stated: sensor and data types have different temporal validity and aggregation requirements, making coherent summary challenging; iterative RADAR-base/app changes meant participants had different user experiences over time; COVID-19 may have affected research experience and data completion; the sample had a higher proportion of White and female individuals than typical populations, limiting generalisability; the paper describes data availability, not quality or completeness, and does not examine predictors of availability.
- Evident from the text: “available” data may include complete, partial, corrupted, or invalid data; baseline depression status is static and may not capture symptom fluctuations relevant to technology use; no formal threshold for acceptable dropout is established, though the authors describe ~80% completion as excellent.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 39 cited sources checked · 0 supported · 0 flagged
- Findingown data
Participants completed a median of 12 speech tasks.
“Overall, participants completed a median of 21 (IQR:9–31) PHQ-8 questionnaires, 20 (IQR:9–30) RSES questionnaires, 12 (IQR:2–23) speech tasks.”
Quote in the paperNot a substantial claim - Findingown data
The symptomatic group had a higher proportion of females.
“In comparison to those with no/some depression symptoms at baseline, the symptomatic group were significantly younger, and had a higher proportion of individuals who were female, on long-term sick leave or unemployed, receiving benefits, and earning less than £/€15,000 per annum.”
Quote in the paperNot a substantial claim - Findingown data
79.8% of participants participated for the maximum possible duration.
“A total of 497 people (79.8%) participated for the maximum possible duration (from their enrolment until the end of data collection in April 2021), and 126 people (20.2%) withdrew prematurely.”
Quote in the paperNot a substantial claim - Findingown data
Participants completed a median of 5 Symbol Check tasks.
“Overall, participants completed a median of 5 (IQR:2–10) THINC-it app® PDQ5 questionnaires, 5 (IQR:2–9) Code Breaker tasks, 5 (IQR:2–9) Spotter tasks, 5 (IQR-2-9) Symbol Check tasks, and 5 (IQR = 2–10) Trails tasks.”
Quote in the paperNot a substantial claim - Findingown data
Fitbit wear-time did not significantly differ between those with no depression symptoms versus those with symptoms at baseline (X2(622, n = 623) = 525616, p=0.24).
“wear-time did not significantly differ between those with no depression symptoms versus those with symptoms at baseline (X2(622, n = 623) = 525616, p=0.24).”
Quote in the paperNot a substantial claim
- Findingown data
Participants completed a median of 5 Code Breaker tasks.
“Overall, participants completed a median of 5 (IQR:2–10) THINC-it app® PDQ5 questionnaires, 5 (IQR:2–9) Code Breaker tasks, 5 (IQR:2–9) Spotter tasks, 5 (IQR-2-9) Symbol Check tasks, and 5 (IQR = 2–10) Trails tasks.”
Quote in the paperNot a substantial claim - Findingown data
Compared with those with no/some baseline depression symptoms, the symptomatic group were significantly younger.
“In comparison to those with no/some depression symptoms at baseline, the symptomatic group were significantly younger, and had a higher proportion of individuals who were female, on long-term sick leave or unemployed, receiving benefits, and earning less than £/€15,000 per annum.”
Quote in the paperNot a substantial claim - Findingown data
Compared to those without baseline depression, those symptomatic at baseline had a significantly larger percentage providing <26% of activity data.
“In comparison to those without depression at baseline, those identified as symptomatic at baseline had a significantly larger percentage of people providing < 26% of activity data.”
Quote in the paperNot a substantial claim - Findingown data
8 participants identified study burden as the main reason for withdrawal.
“A total of 8 participants identified study burden as the main reason for withdrawal, including finding the study “too demanding” (n = 6) or the study “not meeting expectations” (n = 2).”
Quote in the paperNot a substantial claim - Findingown data
The symptomatic group had a higher proportion on long-term sick leave or unemployed.
“In comparison to those with no/some depression symptoms at baseline, the symptomatic group were significantly younger, and had a higher proportion of individuals who were female, on long-term sick leave or unemployed, receiving benefits, and earning less than £/€15,000 per annum.”
Quote in the paperNot a substantial claim - Findingown data
Participants completed a median of 5 Spotter tasks.
“Overall, participants completed a median of 5 (IQR:2–10) THINC-it app® PDQ5 questionnaires, 5 (IQR:2–9) Code Breaker tasks, 5 (IQR:2–9) Spotter tasks, 5 (IQR-2-9) Symbol Check tasks, and 5 (IQR = 2–10) Trails tasks.”
Quote in the paperNot a substantial claim - Findingown data
94.5% of participants had any data available for the RSES.
“A total of 95.3, 94.5 and 82.2% of participants had any data available for the PHQ8, RSES and speech tasks respectively.”
Quote in the paperNot a substantial claim - Findingown data
82.2% of participants had any data available for speech tasks.
“A total of 95.3, 94.5 and 82.2% of participants had any data available for the PHQ8, RSES and speech tasks respectively.”
Quote in the paperNot a substantial claim - Findingown data
20.2% of participants withdrew prematurely.
“A total of 497 people (79.8%) participated for the maximum possible duration (from their enrolment until the end of data collection in April 2021), and 126 people (20.2%) withdrew prematurely.”
Quote in the paperNot a substantial claim - Findingown data
There was no significant difference in ESM data availability between those with and without baseline depression symptoms.
“t-tests demonstrating no significant difference in ESM data availability between these groups (p = 0.158).”
Quote in the paperNot a substantial claim - Findingown data
95.3% of participants had any data available for the PHQ8.
“A total of 95.3, 94.5 and 82.2% of participants had any data available for the PHQ8, RSES and speech tasks respectively.”
Quote in the paperSubstantial claim - Findingown data
There were no significant differences in data availability between those with and without baseline depression for THINC-it tasks.
“Chi squared tests found no significant differences in data availability between those with or without depression at baseline for the PDQ5 (X2 (622, n = 623) = 2.5, p = 0.48), Code Breaker (X2 (622, n = 623) = 0.91, p = 0.82), Spotter (X2 (622, n = 623) = 1.28, p = 0.73), Symbol Check (X2 (622, n = 623) = 1.26, 0.74) or Trails (X2 (622, n = 623) = 2.0, p = 0.58) tasks.”
Quote in the paperNot a substantial claim - Findingown data
The symptomatic group had a higher proportion earning less than £/€15,000 per annum.
“In comparison to those with no/some depression symptoms at baseline, the symptomatic group were significantly younger, and had a higher proportion of individuals who were female, on long-term sick leave or unemployed, receiving benefits, and earning less than £/€15,000 per annum.”
Quote in the paperNot a substantial claim - Findingown data
The symptomatic group had a higher proportion receiving benefits.
“In comparison to those with no/some depression symptoms at baseline, the symptomatic group were significantly younger, and had a higher proportion of individuals who were female, on long-term sick leave or unemployed, receiving benefits, and earning less than £/€15,000 per annum.”
Quote in the paperNot a substantial claim - Findingown data
No evidence of a difference in passive data availability between those with and without baseline depression was identified.
“No evidence of a difference in data availability between those with and without depression at baseline was identified.”
Quote in the paperNot a substantial claim - Findingown data
Over 84% of participants had any data available for the THINC-it tasks.
“Over 84% of participants had any data available for the PDQ5 (90.5%), Code Breaker (84.4%), Spotter (84.8%), Symbol Check (84.6%) and Trails (89.9%) tests.”
Quote in the paperNot a substantial claim - Findingown data
There was no evidence of an association between the severity of depression symptoms at baseline and the availability of data.
“We found no evidence of an association between the severity of depression symptoms at baseline and the availability of data.”
Quote in the paperSubstantial claim - Findingown data
Participants completed a median of 21 PHQ-8 questionnaires.
“Overall, participants completed a median of 21 (IQR:9–31) PHQ-8 questionnaires, 20 (IQR:9–30) RSES questionnaires, 12 (IQR:2–23) speech tasks.”
Quote in the paperNot a substantial claim - Findingown data
Average participant Fitbit wear-time across the entire duration of follow-up was 62.5% (SD 9.1 percentage points).
“the average participant wear-time across the entire duration of follow-up estimated as 62.5% (SD: 9.1 percentage points, Fig. 5b)”
Quote in the paperNot a substantial claim - Findingown data
110 participants (17.7%) had more than 50% data available across all data types/modes.
“In total, 110 participants had > 50% data available across all data types.”
- Also stated in: § Recruitment and retention rates · plain
“with 110 (17.7%) participants having more than 50% available data across all modes of data collection.”
Quote in the paperNot a substantial claim - Also stated in: § Recruitment and retention rates · plain
- Findingown data
The completion rate of primary and secondary outcomes in eligible participants was approximately 80% throughout follow-up assessments.
“We report 80% completion rates for primary outcome assessments across all follow-up timepoints.”
- Also stated in: § Recruitment and retention rates · plain
“The completion rate of the primary and secondary outcomes in those who were eligible to complete it (those who had not already completed the study or been previously withdrawn) was approximately 80% throughout follow-up assessments.”
Quote in the paperSubstantial claim - Also stated in: § Recruitment and retention rates · plain
- Findingown data
623 individuals with a history of MDD were enrolled in RADAR-MDD.
“Individuals with a history of MDD (n = 623) were enrolled in the study,.”
- Also stated in: § Recruitment and retention rates · plain
“Of the 623 participants enrolled in the study, 445 (71.4%) provided outcome data at 1-year follow-up and 181 (29.1%) participated for a full 2-years.”
Quote in the paperSubstantial claim - Also stated in: § Recruitment and retention rates · plain
- Findingown data
The least passive RMT data were available for phone usage.
“The least data were available for phone usage.”
Quote in the paperNot a substantial claim - Findingown data
445 (71.4%) provided outcome data at 1-year follow-up.
“Of the 623 participants enrolled in the study, 445 (71.4%) provided outcome data at 1-year follow-up and 181 (29.1%) participated for a full 2-years.”
Quote in the paperSubstantial claim - Findingown data
Average Fitbit wear-time was 15.1 hours per day (SD 2.2 h).
“and the average number of hours per day as 15.1 h (SD: 2.2 h).”
Quote in the paperNot a substantial claim - Findingown data
The symptomatic group had worsened illness perceptions.
“Regarding clinical characteristics, the symptomatic group had a higher proportion of current smokers, medical comorbidities, as well as increased levels of current depression, anxiety, functional disability, and worsened illness perceptions, although lower levels of alcohol use.”
Quote in the paperNot a substantial claim - Findingown data
Activity data were the only wearable data type with significantly different availability according to baseline depression (X2(622, n=623)=14.1, p=0.002).
“Activity data are also the only data type found to have significantly different levels of availability according to the presence of depression at baseline (X2 (622, n = 623) = 14.1, p = 0.002).”
Quote in the paperNot a substantial claim - Findingown data
The symptomatic group had a higher proportion of medical comorbidities.
“Regarding clinical characteristics, the symptomatic group had a higher proportion of current smokers, medical comorbidities, as well as increased levels of current depression, anxiety, functional disability, and worsened illness perceptions, although lower levels of alcohol use.”
Quote in the paperNot a substantial claim - Findingown data
Participants completed a median of 5 THINC-it PDQ5 questionnaires.
“Overall, participants completed a median of 5 (IQR:2–10) THINC-it app® PDQ5 questionnaires, 5 (IQR:2–9) Code Breaker tasks, 5 (IQR:2–9) Spotter tasks, 5 (IQR-2-9) Symbol Check tasks, and 5 (IQR = 2–10) Trails tasks.”
Quote in the paperNot a substantial claim - Findingown data
181 (29.1%) participated for a full 2 years.
“Of the 623 participants enrolled in the study, 445 (71.4%) provided outcome data at 1-year follow-up and 181 (29.1%) participated for a full 2-years.”
Quote in the paperNot a substantial claim - Findingown data
The target sample size of 600 across the three sites was exceeded.
“The target sample size of 600, across the three sites, was exceeded, with 623 individuals successfully enrolled in the study.”
Quote in the paperNot a substantial claim - Findingown data
Data availability was comparable between active and passive forms of data collection.
“We found comparable levels of data availability in active and passive forms of data collection, demonstrating that both are feasible in this patient group.”
Quote in the paperSubstantial claim - Findingown data
There were no significant differences in data availability between those with and without baseline depression symptoms for PHQ8, RSES, or speech tasks.
“Chi squared tests found no significant differences in data availability between those with or without depression symptoms at baseline for the PHQ8 (X2 (622, n = 623) = 3.0, p = 0.38), RSES (X2 (622, n = 623) = 3.83, p = 0.28), or speech task (X2 = 4.8, p = 0.19).”
Quote in the paperNot a substantial claim - Findingown data
Fitbit wear-time decreased over time.
“Wear-time decreased over time”
Quote in the paperNot a substantial claim - Findingown data
Participants completed a median of 20 RSES questionnaires.
“Overall, participants completed a median of 21 (IQR:9–31) PHQ-8 questionnaires, 20 (IQR:9–30) RSES questionnaires, 12 (IQR:2–23) speech tasks.”
Quote in the paperNot a substantial claim - Findingown data
Participants completed a median of 5 Trails tasks.
“Overall, participants completed a median of 5 (IQR:2–10) THINC-it app® PDQ5 questionnaires, 5 (IQR:2–9) Code Breaker tasks, 5 (IQR:2–9) Spotter tasks, 5 (IQR-2-9) Symbol Check tasks, and 5 (IQR = 2–10) Trails tasks.”
Quote in the paperNot a substantial claim - Findingown data
The median study duration of participation was 541 days (IQR 401-730, range 0-1217).
“resulting in a median study duration of participation of 541 days (interquartile range (IQR): 401–730 days, range: 0–1217 days).”
Quote in the paperNot a substantial claim - Findingown data
Data availability varied across the RMT domains.
“Data availability varied across the RMT domains.”
Quote in the paperSubstantial claim - Findingown data
A total of 110 individuals (17.7% of the sample) had >50% of data for data types.
“We report a total of 110 individuals (17.7% of the sample) who have > 50% of data for data types.”
Quote in the paperSubstantial claim - Findingown data
The RADAR-MDD Fitbit wear-time is lower than the 22.6 h/day across two-year follow-up in Radin et al.'s US population-based Fitbit study.
“This is lower than the wear-time of 22.6 h per day across a two-year follow-up period in a recent United States population-based Fitbit study by Radin and colleagues [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Radin JM, Wineinger NE, Topol EJ, Steinhubl SR. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. Lancet Digit Heal. 2020;11:e85–93. source
Not checked in the free run.
- Findingcitation
The mean age and gender distribution in RADAR-MDD participants is comparable to other MDD samples such as STAR*D and MIDAS.
“The mean age and gender distribution in our participants is comparable to other MDD samples, such as Sequenced Treatment Alternatives to Relieve Depression (STAR*D; [48]) and the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS; [49]).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [48] Trivedi MH, John Rush A, Wisniewski SR, Nierenberg AA, Warden D, Louise Ritz M, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40. source
Not checked in the free run.
- cites [49] Zimmerman M. A review of 20 years of research on overdiagnosis and underdiagnosis in the Rhode Island methods to improve diagnostic assessment and services (MIDAS) project. Can J Psychiatr. 2016. https://doi.org/10.1177/0706743715625935. source
Not checked in the free run.
- Findingown data
Comparable levels of data availability were found in active and passive forms of data collection.
“We found comparable levels of data availability in active (requiring input from the participant) and passive (requiring no input from the participant) forms of data collection”
Quote in the paperSubstantial claim - Findingown data
Median study participation was 541 days.
“We report an overall Fitbit wear-time of 62.5%, across a median study participation of 541 days, and a mean wear-time of 15.1 h per day.”
Quote in the paperNot a substantial claim - Findingnone given
There was no convincing indication that severity of depression symptoms at baseline was associated with data availability in this sample.
“There was no convincing indication that the severity of depression symptoms at baseline was associated with data availability, in this sample.”
Quote in the paperSubstantial claim - Findingcitation
The RADAR-MDD cohort has a higher proportion of White and female individuals than typically seen in the general population or depressed population.
“The RADAR-MDD cohort has a higher proportion of White and female individuals than would typically be seen in the general population or depressed population [45]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Arias de la Torre J, Vilagut G, Ronaldson A, Dregan A, Ricci-Cabello I, Hatch SL, et al. Prevalence and age patterns of depression in the United Kingdom. A population-based study. J Affect Disord. 2021. https://doi.org/10.1016/j.jad.2020.09.129. source
Not checked in the free run.
- Findingown data
The least aRMT data was available for THINC-it assessments, with <26% of expected data available in approximately 60% of participants.
“The least amount of aRMT data was available for all assessments conducted via the THINC-it® app, with < 26% of expected data available in approximately 60% of participants.”
Quote in the paperNot a substantial claim - Findingreasoning
Initial syncing challenges between THINC-it and RADAR-base meant there was potential for data loss in the early months of data collection.
“There were also initial challenges syncing data collected via the THINC-it with the RADAR-base platform, meaning there was potential for data loss in the early months of data collection.”
Quote in the paperNot a substantial claim - Study design and conductcitation
Depression diagnosis was determined using the Lifetime Depression Assessment - Self-Report (LIDAS) in addition to review of medical records.
“Depression diagnosis was determined using the Lifetime Depression Assessment – Self-Report (LIDAS; [22]) in addition to the review of medical records.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Bot M, Middeldorp CM, de Geus EJC, Lau HM, Sinke M, van Nieuwenhuizen B, et al. Validity of LIDAS (LIfetime depression assessment self-report): a self-report online assessment of lifetime major depressive disorder. Psychol Med. 2017;47:279–89. source
Not checked in the free run.
- Interpretationown data
Collecting RMT data from a clinical population is feasible.
“Here, we have shown that collecting RMT data from a clinical population is feasible.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Data availability is a valid indicator of the feasibility of implementing RMT protocols in people with MDD.
- Rests on an assumption: The RADAR-MDD sample of people with a history of recurrent MDD is representative of the clinical population with MDD for assessing feasibility of RMT.
- Premisecitation
In depression, loss of motivation may be a barrier to adherence with digital medicine protocols.
“In depression the illness, characterised by loss of motivation, may be a further barrier to adherence with digital medicine protocols [15, 16].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [15] Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry. 2017;16:287–98. source
Not checked in the free run.
- cites [16] Fleming T, Bavin L, Lucassen M, Stasiak K, Hopkins S, Merry S. Beyond the trial: systematic review of real-world uptake and engagement with digital self-help interventions for depression, low mood, or anxiety. J Med Internet Res. 2018;20:e199. source
Not checked in the free run.
- Study design and conductcitation
The THINC-it app has been validated to identify cognitive dysfunction within the context of depressive disorder.
“The app has been validated to identify cognitive dysfunction within the context of depressive disorder [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] McIntyre RS, Best MW, Bowie CR, Carmona NE, Cha DS, Lee Y, et al. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry. 2017;78:873–81. source
Not checked in the free run.
- Study design and conductcitation
The RADAR-base active RMT app administered validated measurements of depression and self-esteem every 2 weeks via the PHQ8 and RSES.
“The RADAR-base active RMT (aRMT) app administered validated measurements of depression and self-esteem every 2-weeks via the 8-item Patient Health Questionnaire (PHQ8; [25] and Rosenberg Self-Esteem Scale (RSES; 26).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [25] Kroenke K, Strine TW, Spitzer RL, Williams J, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163–73. source
Not checked in the free run.
- cites [26] Greenberger E, Chen C, Dmitrieva J, Farruggia SP. Item-wording and the dimensionality of the Rosenberg self-esteem scale: do they matter? Pers Individ Dif. 2003;35:1241–54. source
Not checked in the free run.
- Study design and conductcitation
The study was designed with patient involvement from the outset.
“The study was designed with patient involvement from the outset (including systematic reviews [19, 20], focus groups [21] and a Patient Advisory Board) with the aim of developing a protocol which meets the needs of the target population.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [19] Simblett S, Greer B, Matcham F, Curtis H, Polhemus A, Ferrão J, et al. Barriers to and facilitators of engagement with remote measurement technology for managing health: systematic review and content analysis of findings. JMIR. 2018;20:210480.
Not checked in the free run.
- cites [20] De Girolamo G, di San B, Pietro C, Bulgari V, Dagani J, Ferrari C, et al. The acceptability of real-time health monitoring among community participants with depression: a systematic review and meta-analysis of the literature. Depression & anxiety. 2020. https://doi.org/10.1002/da.23023. source
Not checked in the free run.
- cites [21] Simblett S, Matcham F, Siddi S, Bulgari V, di San Pietro CB, López JH, et al. Barriers to and facilitators of engagement with mHealth technology for remote measurement and management of depression: qualitative analysis. JMIR mHealth uHealth. 2019. https://doi.org/10.2196/11325. source
Not checked in the free run.
- Study design and conductown data
Depressive state was measured using the IDS-SR and CIDI-SF.
“Depressive state was measured using the Inventory of Depressive Symptomatology – Self Report (IDS-SR; [31]) to capture changes in symptom severity, and the World Health Organisation’s Composite Diagnostic Interview – Short Form (CIDI-SF; [32]) to identify people meeting DSM-5 criteria for MDD at each timepoint.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Rush AJ, Carmody T, Reimitz P-E. The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res. 2000;9:45–59. source
Not checked in the free run.
- cites [32] Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen H-U. The World Health Organization composite international diagnostic interview short-form (CIDI-SF). Int J Methods Psychiatr Res. 1998;7:171–85. source
Not checked in the free run.
- Premisecitation
Recent evidence suggests that people with moderate to severe depression already enrolled in a research study show reduced ability and desire to adhere to research protocols due to COVID-19.
“Recent evidence suggests that people with moderate to severe levels of depression who are already enrolled in a research study show a reduced ability and desire to adhere to research protocols due to COVID-19 [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Cardel MI, Manasse S, Krukowski RA, Ross K, Shakour R, Miller DR, et al. COVID-19 impacts mental health outcomes and ability/desire to participate in research among current research participants. Obesity. 2020. https://doi.org/10.1002/oby.23016. source
Not checked in the free run.
- Interpretationreasoning
An individual participating throughout 2019-2020 will have had a different user experience to an individual participating throughout 2020-2021.
“This means that an individual participating throughout 2019–2020 will have had a different user experience to an individual participating throughout 2020–2021.”
Quote in the paperNot a substantial claim - Interpretationown data
Data availability depends on data type, with higher burden data sources reducing data availability.
“However, data availability will depend on the data type, with higher burden data sources (such as cognitive tasks, or keeping wearable devices charged) reducing data availability.”
Quote in the paperSubstantial claim - Interpretationown data
The data collected in RADAR-MDD indicate that collecting RMT data from clinical populations is feasible.
“The data collected in RADAR-MDD indicates that collecting RMT data from clinical populations is feasible.”
Quote in the paperSubstantial claim - Interpretationreasoning
Our longer follow-up and integration of a wearable into a more complex set of data collection sources likely explains the differences in wear time reported.
“Although similar in clinical characteristics, our duration of follow-up and integration of a wearable into a more complex set of data collection sources likely explains the differences in wear time reported.”
Quote in the paperNot a substantial claim - Premisereasoning
Each sensor and data type collected has different temporal validity and aggregation requirements.
“Firstly, each of the sensor and data types collected has different temporal validity and aggregation requirements.”
Quote in the paperNot a substantial claim - Interpretationreasoning
These sociodemographic characteristics may limit the generalisability of the findings to the wider population.
“These characteristics may limit the generalisability of our findings to the wider population.”
Quote in the paperNot a substantial claim
- May combine two claims. 32
- Classified as probably not a substantial claim. 22
May combine two claims.
Findingown dataThe symptomatic group had increased levels of current depression, anxiety, and functional disability.
“Regarding clinical characteristics, the symptomatic group had a higher proportion of current smokers, medical comorbidities, as well as increased levels of current depression, anxiety, functional disability, and worsened illness perceptions, although lower levels of alcohol use.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataFigure 5a shows lower wear-time between days 290 and 380, and Fig. 5b shows a dip in percentage wear-time in people with baseline depression symptoms after the first year.
“Figure 5a shows a paler horizontal band of colour between days 290 and 380 of study participation, indicating lower levels of wear-time during these time-points, and Fig. 5b shows a dip in percentage wear-time in people with symptoms of depression at baseline after the first year of participation.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationRecruitment into RADAR-MDD was highly successful, exceeding recruitment targets despite the COVID-19 pandemic, due to the flexibility of face-to-face and remote enrolments.
“Recruitment into RADAR-MDD was highly successful, with the flexibility of face-to-face and remote enrolments resulting in the study exceeding its recruitment targets despite the COVID-19 pandemic [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Oetzmann C, White KM, Ivan A, Julie J, Leightley D, Lavelle G, et al. A framework for recruiting into a remote measurement technologies (RMTs) study: Experiences from a major depressive disorder cohort. OSF Preprint. https://doi.org/10.31219/osf.io/ns7dc. source
Not checked in the free run.
May combine two claims.
Findingown dataActivity data were the least readily available wearable data, with only 5% of participants having >75% data availability.
“Activity data (comprising a combination of data derived from Fitbit proprietary algorithms and via participants inputting their own activities manually) was the least readily available data, with only 5% of participants having > 75% data availability.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataStep count data were the most frequently available wearable data, with almost 50% of participants providing >75% of expected data throughout follow-up.
“Step count data were the most frequently available data, with almost 50% of participants providing > 75% of expected data throughout the course of follow-up.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA total of 341 risk assessments were conducted, representing 9.0% of the 3777 depression measurements taken.
“Throughout RADAR-MDD, a total of 341 risk assessments were conducted (9.0% of the 3777 depression measurements taken).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe most common reason for withdrawal was loss to follow-up (n = 47), followed by problems using the Android study phone (n = 14).
“The most common reason for withdrawal across all timepoints was loss to follow-up (n = 47) and problems using the Android study phone (for those who had switched from an iPhone for the purposes of the study (n = 14), representing 37.3 and 11.1% of all withdrawals respectively.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe symptomatic group had lower levels of alcohol use.
“Regarding clinical characteristics, the symptomatic group had a higher proportion of current smokers, medical comorbidities, as well as increased levels of current depression, anxiety, functional disability, and worsened illness perceptions, although lower levels of alcohol use.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA total of 2.9 terabytes of compressed data were collected.
“A total of 2.9 terabytes of compressed data were collected, with 110 (17.7%) participants having more than 50% available data across all modes of data collection.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe symptomatic group had a higher proportion of current smokers.
“Regarding clinical characteristics, the symptomatic group had a higher proportion of current smokers, medical comorbidities, as well as increased levels of current depression, anxiety, functional disability, and worsened illness perceptions, although lower levels of alcohol use.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Findingown dataThe most passive RMT data were available for GPS location and battery level.
“The most data were available for GPS location and battery level data.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe mean numbers of ESM items completed were 11.8 (SD 23.7) for those with baseline depression symptoms and 11.9 (SD 23.7) for those without.
“The mean numbers of ESM items completed by those with and without depression symptoms at baseline throughout the study duration were 11.8 (SD = 23.7) and 11.9 (SD = 23.7) respectively, with t-tests demonstrating no significant difference in ESM data availability between these groups (p = 0.158).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe first THINC-it data were received in March 2018, with the first 4 months of data collection excluding THINC-it data.
“due to the technical requirements of integrating data from the separate THINC-it® app into the RADAR-base platform, the first THINC-it® data were received in March 2018, with the first 4-months of data collection excluding THINC-it® data.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe RADAR-MDD sample has slightly lower levels of current depression severity and reduced WSAS functional disability than those recruited into STAR*D.
“In terms of clinical presentation, our sample have slightly lower levels of current depression severity and reduced WSAS functional disability than those recruited into STAR*D [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Trivedi MH, John Rush A, Wisniewski SR, Nierenberg AA, Warden D, Louise Ritz M, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40. source
Not checked in the free run.
May combine two claims.
Findingown dataOver 90% of participants had data available for analysis from aRMT, with PHQ-8 and RSES having the largest amount of data available for the most people.
“Over 90% of participants had data available for analysis from the aRMT, with the PHQ-8 and RSES having the largest amount of data available for the most people.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRADAR-MDD had approximately 80% completion rates of outcomes across all follow-up timepoints, with 79.8% of enrolled individuals completing the study protocol for the maximum possible time.
“Here we report ~ 80% completion rates of our outcomes across all follow-up timepoints, with 79.8% of all enrolled individuals completing the study protocol for the maximum amount of time possible”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMajor Depressive Disorder (MDD) is prevalent, often chronic, and requires ongoing monitoring of symptoms to track response to treatment and identify early indicators of relapse.
“Major Depressive Disorder (MDD) is prevalent, often chronic, and requires ongoing monitoring of symptoms to track response to treatment and identify early indicators of relapse.”
- Also stated in: § Background · hedged
“Whilst some may experience a single lifetime episode of MDD, it is becoming more widely recognised as a chronic condition, characterised by periods of relapse and recovery [6, 7].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Verduijn J, Verhoeven JE, Milaneschi Y, Schoevers RA, van Hemert AM, Beekman ATF, et al. Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule. BMC Med. 2017. https://doi.org/10.1186/s12916-017-0972-8. source
Not checked in the free run.
- cites [7] Blanco C, Okunda M, Markowitz JC, Liu S-M, Grant BF, Hasin DS. The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatr. 2010;17:1645–56. source
Not checked in the free run.
- Also stated in: § Background · hedged
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe GAD7 threshold of ≥10 has previously been shown to have good levels of sensitivity and specificity.
“This threshold has previously been shown to have good levels of sensitivity and specificity [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Jordan P, Shedden-Mora MC, Löwe B. Psychometric analysis of the generalized anxiety disorder scale (GAD-7) in primary care using modern item response theory. PLoS One. 2017. https://doi.org/10.1371/journal.pone.0182162. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll participants provided written consent.
“All participants provided written consent and provided detailed baseline assessments including sociodemographic, social environment, medical history, medical comorbidities and technology use questionnaires.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe study was co-developed with service users in a Patient Advisory Board, who were involved in choice of measures, timing, engagement, and analysis plan.
“The study was co-developed with service users in our Patient Advisory Board. They were involved in the choice of measures, the timing and issues of engagement and have also been involved in developing the analysis plan and representative(s) are authors of this paper and critically reviewed it.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFollow-up levels of 50, 60 and 70% have previously been described as adequate, good and very good respectively.
“follow-up levels of 50, 60 and 70% have previously been described as adequate, good and very good respectively [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2004;28:2272–81.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent systematic review identified 52 publications testing RMT in depression.
“In a recent systematic review we identified 52 publications testing RMT in depression [17].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] De Angel V, Lewis S, White K, Oetzmann C, Leightley D, Oprea E, et al. Digital health tools for the passive monitoring of depression: A systematic review of methods. npj Digital Medicine. In press. https://doi.org/10.1101/2021.07.19.21260786. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany digital medicine technologies have poor uptake.
“Whilst the wider field of digital medicine has seen vast growth and investment, many technologies have poor uptake [13, 14].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [13] Szinay D, Jones A, Chadborn T, Brown J, Naughton F. Influences on the uptake of and engagement with health and well-being smartphone apps: systematic review. JMIR. 2020. https://doi.org/10.2196/17572. source
Not checked in the free run.
- cites [14] Pham Q, Graham G, Carrion C, Morita PP, Seto E, Stinson JN, et al. A library of analytic indicators to evaluate effective engagement with consumer mHealth apps for chronic conditions: scoping review. JMIR mHealth uHealth. 2019;7:e11941. source
Not checked in the free run.
May combine two claims.
PremisecitationThe literature on RMT in depression is characterised by inconsistent reporting, and data on adherence to protocol are very rarely reported.
“The literature was characterised by inconsistent reporting, and very rarely were data on adherence to protocol reported.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] De Angel V, Lewis S, White K, Oetzmann C, Leightley D, Oprea E, et al. Digital health tools for the passive monitoring of depression: A systematic review of methods. npj Digital Medicine. In press. https://doi.org/10.1101/2021.07.19.21260786. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is no recognised threshold for acceptable versus unacceptable dropout in longitudinal research.
“whilst there is no recognised threshold for “acceptable” versus “unacceptable” dropout”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2004;28:2272–81.
Not checked in the free run.
May combine two claims.
Interpretationown dataBoth active and passive RMT data collection are feasible in this patient group.
“We found comparable levels of data availability in active and passive forms of data collection, demonstrating that both are feasible in this patient group.”
- Also stated in: § Conclusion · boosted
“demonstrating that both are feasible in this patient group.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Data availability is a valid indicator of the feasibility of implementing RMT protocols in people with MDD.
- Rests on an assumption: The RADAR-MDD sample of people with a history of recurrent MDD is representative of the clinical population with MDD for assessing feasibility of RMT.
- Also stated in: § Conclusion · boosted
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe speech task text is phonetically balanced across all three languages and has been shown to provide linguistic parameters indicative of low mood.
“an Aesop’s fable which is phonetically balanced across all three languages and has been shown to provide linguistic parameters indicative of low mood [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Williamson JR, Quatieri TF, Helfer BS, Ciccarellu G, Mehta DD. Vocal and facial biomarkers of dperession based on motor incoordination and timing. In: 4th International Audio/Visual Emotion Challenge and Workshop: Depression Challenge; 2014. https://doi.org/10.1145/2661806.2661809. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenRADAR-MDD is the largest multimodal RMT study in the field of mental health.
“RADAR-MDD is the largest multimodal RMT study in the field of mental health.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenRADAR-base and its associated apps were developed and piloted within the main data collection period, with iterative changes and updates made throughout follow-up.
“RADAR-base and its associated apps were developed and piloted within the main data collection period, with iterative changes and updates being made throughout the course of follow-up.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationRadin et al. used a non-clinical population, and barriers to long-term wearable use are likely different in MDD versus general population.
“In contrast to our sample, Radin et al. [52] used a non-clinical population and the barriers to long-term use of a wearable device are likely to be different in an MDD versus general population sample [21].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [52] Radin JM, Wineinger NE, Topol EJ, Steinhubl SR. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. Lancet Digit Heal. 2020;11:e85–93. source
Not checked in the free run.
- cites [21] Simblett S, Matcham F, Siddi S, Bulgari V, di San Pietro CB, López JH, et al. Barriers to and facilitators of engagement with mHealth technology for remote measurement and management of depression: qualitative analysis. JMIR mHealth uHealth. 2019. https://doi.org/10.2196/11325. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningEthnic groups across the two countries that collected ethnicity data are challenging to compare, meaning in-depth interrogation of racial differences in outcomes will be affected by small cell sizes unless groups are merged.
“It is also worth noting that ethnic groups across the two countries who collected ethnicity data are challenging to compare, meaning that in-depth interrogation of racial differences in outcomes will be affected by small cell sizes unless ethnic groups are merged into larger, less descriptive categories.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIt is likely that fluctuations in depression symptoms over time are more relevant for predicting technology use than a static baseline status.
“it is likely that fluctuations in depression symptoms over time are more relevant for predicting technology use, rather than a static baseline status”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRadin et al. omitted missing wear time data and excluded measurements with wear-time lower than 1000 min/day, which inflates their wear-time statistics.
“However, Radin et al. omitted missing wear time data, and excluded measurements with a wear-time lower than 1000 min per day which inflates their wear-time statistics.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Radin JM, Wineinger NE, Topol EJ, Steinhubl SR. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. Lancet Digit Heal. 2020;11:e85–93. source
Not checked in the free run.
May combine two claims.
InterpretationcitationRADAR-MDD remains the largest, most ambitious multimodal RMT study in depression.
“Despite these limitations, RADAR-MDD remains the largest, most ambitious multimodal RMT study in depression.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] De Angel V, Lewis S, White K, Oetzmann C, Leightley D, Oprea E, et al. Digital health tools for the passive monitoring of depression: A systematic review of methods. npj Digital Medicine. In press. https://doi.org/10.1101/2021.07.19.21260786. source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe majority of recruitment occurred before the global pandemic, but the threat posed by COVID-19 may have affected existing participants' research experience and data completion.
“Whilst the majority of our recruitment occurred before the global pandemic, the threat posed by COVID-19 may have affected existing participants’ research experience and data completion.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
PremisereasoningFor a multiparametric analysis, data across multiple sensor types will be needed.
“For a multiparametric analysis, data across multiple sensor types will be needed.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA recent systematic review found only 5 studies using passive and active smartphone-based measurements in people with MDD, with median sample size 5, median follow-up 4 weeks, and huge variability in reporting quality.
“A recent systematic review summarising studies using passive and active smartphone-based measurements in affective disorders found only 5 studies in people with MDD, and these studies reported a median sample size of 5, and median follow-up time of 4 weeks, in addition to huge variability in the quality of reporting [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] De Angel V, Lewis S, White K, Oetzmann C, Leightley D, Oprea E, et al. Digital health tools for the passive monitoring of depression: A systematic review of methods. npj Digital Medicine. In press. https://doi.org/10.1101/2021.07.19.21260786. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningAt a granular level, smartphone and wearable sensor data are so fine that no meaningful inferences can be gained, requiring some form of aggregation which may not be the same across different sensors.
“At a granular level, data from smartphone and wearable sensors are so fine that no meaningful inferences can be gained, requiring some form of aggregation which may not be the same across different sensors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAttrition rates in longitudinal research vary widely.
“Attrition rates in longitudinal research vary widely [43]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Gustavson K, Von Soest T, Karevold E, Roysamb E. Attrition and generalizability in longitudinal studies: findings from a 15-year population-based study and a Monte Carlo simulation study. BMC Public Health. 2012. https://doi.org/10.1186/1471-2458-12-918. source
Not checked in the free run.
May combine two claims.
InterpretationcitationGiven the high level of depressive symptoms in the sample, the pandemic and associated social interventions may have added burden resulting in increased dropout and reduced adherence.
“Given the high level of depressive symptoms in our sample, the pandemic and its associated social interventions may have added a burden to participants resulting in an increased dropout rate and reduced adherence to the study protocol.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThe THINC-it app being separate with different branding may have made tasks appear separate and reduced adherence.
“Secondly, the THINC-it® app is separate to the other RADAR-base apps, with different branding, design and feel to the RADAR-base apps. This may have made the tasks appear separate or “other” to the main protocol and reduced adherence to these tasks.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe THINC-it app lacks an inbuilt notification system, requiring participants to switch between apps, which increases points at which interest or motivation may be lost.
“The THINC-it® app does not have an inbuilt notification system - participants received notifications to complete the cognitive tasks via the RADAR-base aRMT app. Participants are required to switch between apps, which increases the number of points at which interest or motivation may be lost [50].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Dahl AJ, D’Alessandro AM, Peltier JW, Swan EL. Differential effects of omni-channel touchpoints and digital behaviors on digital natives’ social cause engagement. J Res Interact Mark. 2018;12:258–73. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenSleep data are only meaningful when aggregated from midday-midday, whereas activity data are more relevant when calculated from midnight-midnight.
“For example, sleep data are only meaningful when aggregated from midday-midday, whereas activity data are more relevant when calculated from midnight-midnight.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPedrelli et al. 2020 reported Empatica E4 wear-time estimates of 92-94% in 31 individuals with MDD, but follow-up was limited to 8 weeks.
“Comparatively, Pedrelli et al., 2020 [53] report Empatica E4 wear-time estimates of 92–94% in their study involving 31 individuals with MDD, however their follow-up period was limited to only 8-weeks [53].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Pedrelli P, Fedor S, Ghandeharioun A, Howe E, Ionescu DF, Bhathena D, et al. Monitoring changes in depression severity using wearable and mobile sensors. Front Psychiatry. 2020;11:584711. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe approximately 80% completion and 79.8% protocol completion represent excellent availability of primary and secondary outcome measures.
“representing excellent availability of our primary and secondary outcome measures.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationCognitive tasks in THINC-it require more attention than conventional questionnaires, which may be more challenging for those experiencing depression symptoms.
“Finally, the cognitive tasks offered as part of the THINC-it requires more attention than conventional questionnaires which may be more challenging for those who are experiencing depression symptoms [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Peterson JZ, Porter RJ, Miskowiak KW. Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment indepression. J Affect Dis. 2019;246:763–74. source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe higher proportion of White and female individuals reflects the tendency for White females to attend mental health services more often and their greater likelihood of participating in research studies.
“reflecting the tendency for White females to attend mental health services more often than their male/non-White counterparts, and their greater likelihood of participating in research studies [46, 47].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [46] Manuel JI. Racial/ethnic and gender disparities in health care use and access. Health Serv Res. 2018. https://doi.org/10.1111/1475-6773.12705. source
Not checked in the free run.
- cites [47] Brown G, Marshall M, Bower P, Woodham A, Waheed W. Barriers to recruiting ethnic minorities to mental health research: a systematic review. Int J Methods Psychiatr Res. 2014. https://doi.org/10.1002/mpr.1434. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe 110 individuals with >50% data is an indicator of the amount of resource and data collection required for multiparametric analyses.
“It is important to acknowledge this as an indicator of the amount of resource and data collection required for multiparametric analyses.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
Data availability is a valid indicator of the feasibility of implementing RMT protocols in people with MDD.
“We believe it is essential to include partial or incomplete data as part of this paper, as they are indicative not only of participant characteristics and study burden, but also of the underlying technical infrastructure.”
“This concession gives greater insight into how data availability may fluctuate with changes in depressive state and provides a truer representation of the feasibility of implementing RMT protocols in people with MDD.”
The paper relies on this without support.
The RADAR-MDD sample of people with a history of recurrent MDD is representative of the clinical population with MDD for assessing feasibility of RMT.
“Here, we have shown that collecting RMT data from a clinical population is feasible.”
The paper relies on this without support.
No remote measurement studies have reported the quantity of data collected via smartphone sensors.
“To the best of our knowledge, no remote measurement studies have reported the quantity of data collected via smartphone sensors.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Remote sensing measures, such as actigraphy, may be a promising objective measure of behaviour that can be standardized to an individual's baseline.
“Remote sensing measures, such as actigraphy, may be a promising objective measure of behaviour that can be standardized to an individual's baseline. 29”
Remote biosensors can assess potential biomarkers such as motor activity and sleep patterns over long periods.
“Remote biosensors can assess potential biomarkers such as motor activity and sleep patterns over long periods.29–31”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Passive-data summary contradicts its table
MajorThe passive-data results say no difference in availability was identified, but Table 3 reports significant differences for app use (p = 0.02) and phone interactions (p = 0.03).
“No evidence of a difference in data availability between those with and without depression at baseline was identified.”
“| Phone interactionsc | 0–25% | 237 (38.0) | 83 (33.9) | 154 (40.7) | 8.8 (0.03) |”
Calorie-intake availability percentage is incorrect
MinorThe 87 participants in this category represent 14.0% of the 623-person sample, not 19.6%.
Reported 19.6 · recomputed 13.964687
“| Calorie intakec | 26–50% | 87 (19.6) | 31 (12.7) | 56 (14.8) | |”
Marital-status subgroup percentage is incorrect
MinorThe 119 participants in this category represent 48.6% of the 245-person no/some-symptoms group, not 47.8%.
Reported 47.8 · recomputed 48.571429
“| Marital Status, N(%) | Single/separated/divorced/widowed | 332 (53.3) | 119 (47.8) | 213 (56.2) | 0.070 |”
Phone-interactions subgroup percentage is incorrect
MinorAmong the 245 participants with no/some baseline symptoms, 225 represent 91.8%, not 9.2%.
Reported 9.2 · recomputed 91.836735
“| Phone interactionsc | Any data | 584 (93.7) | 225 (9.2) | 359 (95.0 | |”
Alcohol-dependence cutoff differs between methods and table
MinorThe methods specify scores greater than 20 as indicating likely alcohol dependence, whereas Table 1 labels scores greater than 19 that way. A score of 20 is classified differently.
“and scores > 20 indicate likely alcohol dependence [37].”
“| Alcohol use | Addiction likely (> 19), N(%) | 8 (1.3) | 5 (2.0) | 3 (0.8) | |”
Steps no-data percentage is incorrect
MinorTable 2 lists 36 participants without steps data out of 623, which is 5.8%, not 6.8%.
Reported 6.8 · recomputed 5.778491
“| Steps | No data | 36 (6.8) | 16 (6.6) | 20 (5.3) | |”
Activity-data subgroup percentage is incorrect
MinorIn the 245-person no/some-symptoms group, 53 participants represent 21.6%, not 51.6%.
Reported 51.6 · recomputed 21.632653
“| Activity | 26–50% | 143 (23.0) | 53 (51.6) | 90 (23.8) | |”
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · see citing works
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · cited 1× · see citing works
“Anxiety was measured via the 7-item Generalised Anxiety Disorder questionnaire (GAD7; [33]), used as a continuous indicator of anxiety symptom severity (a total of 21, with higher scores indicating increased anxiety severity) and a total score ≥ 10 indicating significant symptoms.”
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867 · see citing works
The PHQ-8 as a measure of current depression in the general population
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.026 · Cited by 5,121 · cited 2× · see citing works
“Active RMT The RADAR-base active RMT (aRMT) app administered validated measurements of depression and selfesteem every 2-weeks via the 8-item Patient Health Questionnaire (PHQ8; [25] and Rosenberg Self-Esteem Scale (RSES; 26).”
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 3× · see citing works
“In terms of clinical presentation, our sample have slightly lower levels of current depression severity and reduced WSAS functional disability than those recruited into STAR*D [48].”
InfluentialThe Brief Illness Perception Questionnaire
Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2005.10.020 · Cited by 3,431 · cited 1× · see citing works
“Illness perceptions The Brief Illness Perceptions Questionnaire (BIPQ; [38]) measured emotional and cognitive representations of illness, capturing perceptions relating to illness identity, causes, control, consequences, timeline, concern, understanding and emotional response.”
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515 · cited 1× · see citing works
“Functional ability Functional ability was measured using the Work and Social Adjustment Scale (WSAS; [35]), using a continuous score from 0 to 40 to describe the level of impairment, with scores of 0–10, 11–20 and > 20 to indicate no, some and significant impairment respectively [35].”
The world health organization composite international diagnostic interview short-form (CIDI-SF)
Kessler, R. C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H. (1998) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.47 · Cited by 2,242 · cited 1× · see citing works
“Depression Depressive state was measured using the Inventory of Depressive Symptomatology – Self Report (IDS-SR; [31]) to capture changes in symptom severity, and the World Health Organisation’s Composite Diagnostic Interview – Short Form (CIDI-SF; [32]) to identify people meeting DSM-5 criteria for MDD at each timepo…”
Firth, J., Torous, J., Nicholas, J., Carney, R., Pratap, A., Rosenbaum, S., & Sarris, J. (2017) · World Psychiatry · doi:10.1002/wps.20472 · Cited by 1,097 · cited 1× · see citing works
“In depression the illness, characterised by loss of motivation, may be a further barrier to adherence with digital medicine protocols [15, 16].”
Brugha, T. S., & Cragg, D. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb01360.x · Cited by 883 · cited 1× · see citing works
“Any significant life events which may have happened between outcome assessments were measured via the List of Threatening Experiences Questionnaire (LTE-Q; [40]).”
Experience sampling research in psychopathology: opening the black box of daily life
Myin-Germeys, I., Oorschot, M., Collip, D., Lataster, J., Delespaul, P., & van Os, J. (2009) · Psychological Medicine · doi:10.1017/s0033291708004947 · Cited by 817 · cited 1× · see citing works
“It could further be used to predict future changes in health states – for example signals might be identified to predict a relapse in an otherwise healthy individual [12].”
Self-citationLoss to follow-up in cohort studies: how much is too much?
Kristman, V., Manno, M., & Côté, P. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000036568.02655.f8 · Cited by 740 · cited 1× · see citing works
“…number of participants not indicated as symptomatic. b total number of symptomatic: participants meeting criteria for MDD on the CIDI-SF and scoring > 25 “unacceptable” dropout, follow-up levels of 50, 60 and 70% have previously been described as adequate, good and very good respectively [44].”
Gustavson, K., von Soest, T., Karevold, E., & Røysamb, E. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-918 · Cited by 679 · see citing works
Fleming, T., Bavin, L., Lucassen, M., Stasiak, K., Hopkins, S., & Merry, S. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9275 · Cited by 670 · see citing works
Chan, A. H. Y., Horne, R., Hankins, M. C., & Chisari, C. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14193 · Cited by 530 · cited 1× · see citing works
“Medication adherence Self-reported adherence to depression medication was measured with the 5-item Medication Adherence Report Scale (MARS-5; [41]).”
Chisholm, D., Knapp, M. R. J., Knudsen, H. C., Amaddeo, F., Gaite, L., van Wijngaarden, B., & EPSILON Study Group (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.39.s28 · Cited by 480 · cited 2× · see citing works
“Changes in employment status were recorded regularly as part of the CSRI [39].”
Rush, A. J., Carmody, T., & Reimitz, P. (2000) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.79 · Cited by 427 · see citing works
Systematic review of smartphone-based passive sensing for health and wellbeing
Cornet, V. P., & Holden, R. J. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.12.008 · Cited by 406 · cited 1× · see citing works
“Data such as Global Positioning System (GPS), Bluetooth, gyroscope, phone screen interactions, ambient noise and light levels have also been used to collect information from smartphones relating to sociability, movement and activity associated with low mood [11].”
Item-wording and the dimensionality of the Rosenberg Self-Esteem Scale: do they matter?
Greenberger, E., Chen, C., Dmitrieva, J., & Farruggia, S. P. (2003) · Personality and Individual Differences · doi:10.1016/s0191-8869(02)00331-8 · Cited by 380 · see citing works
Racial/Ethnic and Gender Disparities in Health Care Use and Access
Manuel, J. I. (2018) · Health Services Research · doi:10.1111/1475-6773.12705 · Cited by 378 · cited 1× · see citing works
“Sociodemographic characteristics The RADAR-MDD cohort has a higher proportion of White and female individuals than would typically be seen in the general population or depressed population [45] reflecting the tendency for White females to attend mental health services more often than their male/non-White counterparts,…”
Radin, J. M., Wineinger, N. E., Topol, E. J., & Steinhubl, S. R. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30222-5 · Cited by 300 · see citing works
Szinay, D., Jones, A., Chadborn, T., Brown, J., & Naughton, F. (2020) · Journal of Medical Internet Research · doi:10.2196/17572 · Cited by 289 · see citing works
Simblett, S., Greer, B., Matcham, F., Curtis, H., Polhemus, A., Ferrão, J., Gamble, P., & Wykes, T. (2018) · Journal of Medical Internet Research · doi:10.2196/10480 · Cited by 270 · cited 1× · see citing works
“The study was designed with patient involvement from the outset (including systematic reviews [19, 20], focus groups [21] and a Patient Advisory Board) with the aim of developing a protocol which meets the needs of the target population.”
Self-citationUsing Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19
Sun, S., Folarin, A. A., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., Cummins, N., Matcham, F., Dalla Costa, G., Simblett, S., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/19992 · Cited by 256 · see citing works
Self-citationDaeppen, J., Yersin, B., Landry, U., Pécoud, A. R., & Decrey, H. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02037.x · Cited by 246 · cited 1× · see citing works
“The Alcohol Use Disorders Identification Test (AUDIT; [36]) was used to measure alcohol use across timepoints.”
Ranjan, Y., Rashid, Z., Stewart, C., Kerz, M., Begale, M. J., Verbeeck, D., Boettcher, S., Conde, P., Hyve, T., Dobson, R., et al. (2018) · JMIR mhealth and uhealth · doi:10.2196/11734 · Cited by 229 · see citing works
Self-citationDigital Health Tools for the Passive Monitoring of Depression: A Systematic Review of Methods
de Angel, V., Lewis, S., White, K., Oetzmann, C., Leightley, D., Oprea, E., Lavelle, G., Matcham, F., Pace, A., Mohr, D. C., et al. (2021) · doi:10.1101/2021.07.19.21260786 · Cited by 227 · cited 2× · see citing works
“…summarising studies using passive and active smartphone-based measurements in affective disorders found only 5 studies in people with MDD, and these studies reported a median sample size of 5, and median follow-up time of 4 weeks, in addition to huge variability in the quality of reporting [17].”
Self-citationJordan, P., Shedden-Mora, M. C., & Löwe, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182162 · Cited by 225 · see citing works
Vocal and Facial Biomarkers of Depression based on Motor Incoordination and Timing
Williamson, J. R., Quatieri, T. F., Helfer, B. S., Ciccarelli, G., & Mehta, D. D. (2014) · Proceedings of the 4th International Workshop on Audio/Visual Emotion Challenge · doi:10.1145/2661806.2661809 · Cited by 209 · see citing works
WELLS, J. E., & HORWOOD, L. J. (2004) · Psychological Medicine · doi:10.1017/s0033291703001843 · Cited by 199 · cited 1× · see citing works
“conducted at clinic visits) and reliant on individuals’ recollection of symptoms, and subject to recall bias [8].”
Cambridge, O. R., Knight, M. J., Mills, N. T., & Baune, B. T. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.033 · Cited by 186 · cited 1× · see citing works
“MDD is associated with a wide range of negative outcomes including: loss of occupational function [3], reduced quality-of-life [4], and premature mortality [5].”
McIntyre, R. S., Best, M. W., Bowie, C. R., Carmona, N. E., Cha, D. S., Lee, Y., Subramaniapillai, M., Mansur, R. B., Barry, H., Baune, B. T., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11329 · Cited by 172 · cited 2× · see citing works
“…along-side computerised versions of the Choice Reaction Time Identification Task (“Code Breaker”), One-Back Test (“Spotter”), Digit Symbol Substitution Test (“Symbol Check”) and Trail Making Test-Part B (“Trails”) tasks to assess processing speed, working memory, concentration and attention [28].”
Barriers to recruiting ethnic minorities to mental health research: a systematic review
Brown, G., Marshall, M., Bower, P., Woodham, A., & Waheed, W. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1434 · Cited by 158 · see citing works
Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors
Pedrelli, P., Fedor, S., Ghandeharioun, A., Howe, E., Ionescu, D. F., Bhathena, D., Fisher, L. B., Cusin, C., Nyer, M., Yeung, A., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.584711 · Cited by 158 · cited 1× · see citing works
“Comparatively, Pedrelli et al., 2020 [53] report Empatica E4 wear-time estimates of 92–94% in their study involving 31 individuals with MDD, however their follow-up period was limited to only 8-weeks [53].”
Babor, T. F., & Robaina, K. (2016) · The International Journal of Alcohol and Drug Research · doi:10.7895/ijadr.v5i2.222 · Cited by 147 · see citing works
Blanco, C., Okuda, M., Markowitz, J. C., Liu, S.-M., Grant, B. F., & Hasin, D. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05663gry · Cited by 144 · see citing works
Matcham, F., Pietro, C. B. D. S., Bulgari, V., de Girolamo, G., Dobson, R., Eriksson, H., Folarin, A., Haro, J. M., Kerz, M., Lamers, F., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2049-z · Cited by 141 · see citing works
Self-citationPham, Q., Graham, G., Carrion, C., Morita, P. P., Seto, E., Stinson, J. N., & Cafazzo, J. A. (2019) · JMIR mHealth and uHealth · doi:10.2196/11941 · Cited by 131 · see citing works
Verduijn, J., Verhoeven, J. E., Milaneschi, Y., Schoevers, R. A., van Hemert, A. M., Beekman, A. T. F., & Penninx, B. W. J. H. (2017) · BMC Medicine · doi:10.1186/s12916-017-0972-8 · Cited by 122 · cited 1× · see citing works
“Whilst some may experience a single lifetime episode of MDD, it is becoming more widely recognised as a chronic condition, characterised by periods of relapse and recovery [6, 7].”
Self-citationSimblett, S., Matcham, F., Siddi, S., Bulgari, V., Barattieri di San Pietro, C., Hortas López, J., Ferrão, J., Polhemus, A., Haro, J. M., de Girolamo, G., et al. (2019) · JMIR mHealth and uHealth · doi:10.2196/11325 · Cited by 120 · cited 2× · see citing works
“[52] used a non-clinical population and the barriers to long-term use of a wearable device are likely to be different in an MDD versus general population sample [21].”
Self-citationSaragoussi, D., Christensen, M. C., Hammer-Helmich, L., Rive, B., Touya, M., & Haro, J. M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s159276 · Cited by 110 · cited 2× · see citing works
“MDD is associated with a wide range of negative outcomes including: loss of occupational function (3); reduced quality-of-life (4); and premature mortality (5).”
Self-citationLam, R., Lamy, F.-X., Danchenko, N., Yarlas, A., White, M. K., Rive, B., & Saragoussi, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s175188 · Cited by 101 · see citing works
Petersen, J. Z., Porter, R. J., & Miskowiak, K. W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.105 · Cited by 98 · see citing works
Prevalence and age patterns of depression in the United Kingdom. A population-based study
Arias de la Torre, J., Vilagut, G., Ronaldson, A., Dregan, A., Ricci-Cabello, I., Hatch, S. L., Serrano-Blanco, A., Valderas, J. M., Hotopf, M., & Alonso, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.129 · Cited by 92 · cited 1× · see citing works
“Sociodemographic characteristics The RADAR-MDD cohort has a higher proportion of White and female individuals than would typically be seen in the general population or depressed population [45] reflecting the tendency for White females to attend mental health services more often than their male/non-White counterparts,…”
Self-citationDavies, M. R., Kalsi, G., Armour, C., Jones, I. R., McIntosh, A. M., Smıth, D. J., Walters, J., Bradley, J. R., Kingston, N., Ashford, S. E., et al. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103503 · Cited by 91 · cited 1× · see citing works
“…recruitment channels, including through existing research cohorts who have consented to be contacted for future research opportunities (in the UK [23] and the Netherlands), through primary and secondary mental health services (in the UK and Barcelona), or through advertisements for the study…”
Self-citationZimmerman, M. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743715625935 · Cited by 83 · see citing works
Mohr, D. C., Shilton, K., & Hotopf, M. H. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0251-5 · Cited by 82 · cited 1× · see citing works
“These technologies provide the opportunity to collect data using unobtrusive, inbuilt sensors requiring minimal input from users [9, 10].”
Self-citationCardel, M. I., Manasse, S., Krukowski, R. A., Ross, K., Shakour, R., Miller, D. R., Lemas, D. J., & Hong, Y. (2020) · Obesity · doi:10.1002/oby.23016 · Cited by 59 · cited 1× · see citing works
“Recent evidence suggests that people with moderate to severe levels of depression who are already enrolled in a research study show a reduced ability and desire to adhere to research protocols due to COVID-19 [54].”
Bot, M., Middeldorp, C. M., de Geus, E. J. C., Lau, H. M., Sinke, M., van Nieuwenhuizen, B., Smit, J. H., Boomsma, D. I., & Penninx, B. W. J. H. (2017) · Psychological Medicine · doi:10.1017/s0033291716002312 · Cited by 56 · cited 1× · see citing works
“Depression diagnosis was determined using the Lifetime Depression Assessment – Self-Report (LIDAS; [22]) in addition to the review of medical records.”
Self-citationMiloyan, B. H., & Fried, E. I. (2017) · World Psychiatry · doi:10.1002/wps.20439 · Cited by 53 · cited 1× · see citing works
“MDD is associated with a wide range of negative outcomes including: loss of occupational function [3], reduced quality-of-life [4], and premature mortality [5].”
Beratis, S., Katrivanou, A., Georgiou, S., Monastirli, A., Pasmatzi, E., Gourzis, P., & Tsambaos, D. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.03.010 · Cited by 43 · cited 1× · see citing works
“Major depressive disorder (MDD) is a severe form of depression characterised by prolonged periods of low mood and anhedonia combined with a range of other symptoms including changes in sleep quality, appetite, cognitive function, energy levels, activity, feelings of guilt or worthlessness and thoughts of death [2].”
Dahl, A. J., D’Alessandro, A. M., Peltier, J. W., & Swan, E. L. (2018) · Journal of Research in Interactive Marketing · doi:10.1108/jrim-04-2018-0051 · Cited by 39 · cited 1× · see citing works
“Participants are required to switch between apps, which increases the number of points at which interest or motivation may be lost [50].”
Girolamo, G., Barattieri di San Pietro, C., Bulgari, V., Dagani, J., Ferrari, C., Hotopf, M., Iannone, G., Macis, A., Matcham, F., Myin‐Germeys, I., et al. (2020) · Depression and Anxiety · doi:10.1002/da.23023 · Cited by 24 · see citing works
Self-citationDigital technology: coming of age?
Marzano, L., Hollis, C. P., Cipriani, A., & Malhi, G. S. (2017) · Evidence-Based Mental Health · doi:10.1136/eb-2017-102821 · Cited by 14 · cited 1× · see citing works
“These technologies provide the opportunity to collect data using unobtrusive, inbuilt sensors requiring minimal input from users [9, 10].”
Oetzmann, C., White, K. M., Ivan, A., Julie, J., Leightley, D., Lavelle, G., Lamers, F., Siddi, S., Annas, P., Garcia, S. A., et al. (2021) · doi:10.31219/osf.io/ns7dc · Cited by 5 · cited 1× · see citing works
“Recruitment into RADAR-MDD was highly successful, with the flexibility of face-to-face and remote enrol-ments resulting in the study exceeding its recruitment targets despite the COVID-19 pandemic [42].”
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Cohen, A., Naslund, J. A., Chang, S., Nagendra, S., Bhan, A., Rozatkar, A., Thirthalli, J., Bondre, A., Tugnawat, D., Reddy, P. V., et al. (2023) · Schizophrenia · doi:10.1038/s41537-023-00332-5 · Cited by 90 · see citing works
Leaning, I. E., Ikani, N., Savage, H. S., Leow, A., Beckmann, C. F., Ruhé, H. G., & Marquand, A. F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105541 · Cited by 82 · see citing works
“The general aim of this review was, therefore, to investigate the current state of digital phenotyping research for populations with MDD, in particular to establish what current methods are able to achieve in terms of their predictive power, and where subsequent efforts need to be focused to advance digital phenotypin…”
BackgroundInfluentialJiang, Z., Seyedi, S. S., Griner, E. L., Abbasi, A., Rad, A. B., Kwon, H., Cotes, R. O., & Clifford, G. D. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3352075 · Cited by 75 · see citing works
“This begs the question of whether data collected remotely, such as in [44], [45], and in our previous research protocol [13], can provide a comparable level of information as the data collected in a lab-controlled environment.”
Zhang, Y., Pratap, A., Folarin, A., Sun, S., Cummins, N., Matcham, F., Vairavan, S., Dineley, J., Ranjan, Y., Rashid, Z., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00749-3 · Cited by 58 · see citing works
“The detailed study protocol and descriptions of the dataset have been reported by Matcham et al.10,28.”
MethodSelf-citationWearable Technology in Clinical Practice for Depressive Disorder
Fedor, S., Lewis, R., Pedrelli, P., Mischoulon, D., Curtiss, J. E., & Picard, R. W. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215898 · Cited by 57 · see citing works
Ali, M., Ali, S., Abbas, Q., Abbas, Z., & Lee, S. (2025) · Digital Health · doi:10.1177/20552076251395548 · Cited by 72 · see citing works
Screening for Depression Using Natural Language Processing: Literature Review
Teferra, B. G., Rueda, A., Pang, H. Y. M., Valenzano, R., Samavi, R., Krishnan, S., & Bhat, V. (2024) · Interactive Journal of Medical Research · doi:10.2196/55067 · Cited by 51 · see citing works
“In another dataset, as presented in the study by Matcham et al [56], they presented data collected from 623 participants with a history of recurrent major depressive disorder.”
MethodZhang, Y., Folarin, A., Sun, S., Cummins, N., Vairavan, S., Bendayan, R., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., et al. (2022) · JMIR Mental Health · doi:10.2196/34898 · Cited by 43 · see citing works
“All participants in the study had at least one diagnosis of depression in the most recent 2 years and were recruited from 3 countries (Netherlands, Spain, and the United Kingdom); additional details descriptions are reported in [28].”
Self-citationMultilingual markers of depression in remotely collected speech samples: A preliminary analysis
Cummins, N., Dineley, J., Conde, P., Matcham, F., Siddi, S., Lamers, F., Carr, E., Lavelle, G., Leightley, D., White, K. M., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.08.097 · Cited by 51 · see citing works
Self-citationStolfi, F., Abreu, H., Sinella, R., Nembrini, S., Centonze, S., Landra, V., Brasso, C., Cappellano, G., Rocca, P., & Chiocchetti, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1422939 · Cited by 49 · see citing works
Matcham, F., Simblett, S. K., Leightley, D., Dalby, M., Siddi, S., Haro, J. M., Lamers, F., Penninx, B. W. J. H., Bruce, S., Nica, R. I., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722003671 · Cited by 43 · see citing works
Self-citationCurrey, D., & Torous, J. B. (2023) · BMJ Mental Health · doi:10.1136/bmjment-2023-300718 · Cited by 43 · see citing works
Sun, S., Folarin, A., Zhang, Y., Cummins, N., Garcia‐Dias, R., Stewart, C., Ranjan, Y., Rashid, Z., Conde, P., Laiou, P., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/45233 · Cited by 42 · see citing works
“We previously elaborated issues in relation to recruitment, retention, data availability, and predictors of engagement [30].”
BackgroundSelf-citationPersonalized mood prediction from patterns of behavior collected with smartphones
Balliu, B., Douglas, C., Seok, D., Shenhav, L., Wu, Y., Chatzopoulou, D., Kaiser, W., Chen, V., Kim, J. S., Deverasetty, S., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01035-6 · Cited by 37 · see citing works
Siddi, S., Bailon, R., Giné-Vázquez, I., Matcham, F., Lamers, F., Kontaxis, S., Laporta, E., Garcia, E., Lombardini, F., Annas, P., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723001034 · Cited by 31 · see citing works
Self-citationZhang, Y., Folarin, A., Sun, S., Cummins, N., Ranjan, Y., Rashid, Z., Stewart, C., Conde, P., Sankesara, H., Laiou, P., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/55302 · Cited by 30 · see citing works
“Further details can be found in the study protocol and data description papers [40,41].”
InfluentialSelf-citationZhang, Y., Folarin, A., Dineley, J., Conde, P., de Angel, V., Sun, S., Ranjan, Y., Rashid, Z., Stewart, C., Laiou, P., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.106 · Cited by 27 · see citing works
Self-citationLinardon, J., Chen, K., Gajjar, S., Eadara, A., Wang, S., Flathers, M., Burns, J., & Torous, J. B. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116483 · Cited by 32 · see citing works
Passively sensing smartphone use in teens with rates of use by sex and across operating systems
Alexander, J. D., Linkersdörfer, J., Toda-Thorne, K., Sullivan, R. M., Cummins, K. M., Tomko, R. L., Allen, N. B., Bagot, K. S., Baker, F. C., Fuemmeler, B. F., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68467-8 · Cited by 27 · see citing works
“Although these rates of missingness are not out of line with the field of sensor-based phone data (e.g., 35 ), caution is warranted to consider reasons for missingness and the potential influence on research aims, particularly with iOS variables.”
Backgroundde Angel, V., Adeleye, F., Zhang, Y., Cummins, N., Munir, S., Lewis, S., Laporta, E., Matcham, F., Sun, S., Folarin, A., et al. (2022) · JMIR Mental Health · doi:10.2196/42866 · Cited by 25 · see citing works
“…7 months is markedly lower than the 94% retention after a 9-month follow-up in a sample at different stages of recurrent major depressive disorder [15], yet it is higher than the 50% retention after 15 days in a self-referral study with little researcher contact [13] and the 53% retention in…”
InfluentialSelf-citationValue of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies
Goodday, S., Karlin, E., Brooks, A., Chapman, C., Harry, C., Lugo, N., Peabody, S., Rangwala, S., Swanson, E., Tempero, J., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/57827 · Cited by 24 · see citing works
“Importantly, the included studies in this analysis involved high burden designs in comparison to other studies that request, for example, weekly or biweekly active tasks of participants [14] or only involve the use of a smartwatch.”
Rashid, Z., Folarin, A., Zhang, Y., Ranjan, Y., Conde, P., Sankesara, H., Sun, S., Stewart, C., Laiou, P., & Dobson, R. (2024) · JMIR Mental Health · doi:10.2196/51259 · Cited by 22 · see citing works
Self-citationOetzmann, C., White, K. M., Ivan, A., Julie, J., Leightley, D., Lavelle, G., Lamers, F., Siddi, S., Annas, P., Arranz, S., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00680-z · Cited by 21 · see citing works
Self-citationZhang, Y., Folarin, A., Sun, S., Cummins, N., Vairavan, S., Qian, L., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., et al. (2022) · JMIR mhealth and uhealth · doi:10.2196/40667 · Cited by 20 · see citing works
“The EU research program RADAR-MDD aimed to investigate the utility of mobile technologies for the long-term monitoring of participants with depression in real-world settings [35,40].”
MethodSelf-citationWhite, K. M., Dawe‐Lane, E., Siddi, S., Lamers, F., Simblett, S. K., Alacid, G. R., Ivan, A., Myin‐Germeys, I., Haro, J. M., Oetzmann, C., et al. (2023) · JMIR Human Factors · doi:10.2196/39479 · Cited by 19 · see citing works
“The RADAR-MDD study has recently reported promising engagement, both in terms of initial recruitment rates [18] and sustained retention and data availability [19] over a 2-year follow-up of 623 participants across 3 European sites (United Kingdom, Spain, and the Netherlands).”
BackgroundSelf-citationThe relationship between wearable-derived sleep features and relapse in Major Depressive Disorder
Matcham, F., Carr, E., Meyer, N., White, K. M., Oetzmann, C., Leightley, D., Lamers, F., Siddi, S., Cummins, N., Annas, P., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.136 · Cited by 25 · see citing works
“We have previously published recruitment rates, retention rates, and data availability for the RADAR-MDD study (Matcham et al., 2022).”
Self-citationBryan, A. C., Heinz, M. V., Salzhauer, A. J., Price, G. D., Tlachac, M., & Jacobson, N. C. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-023-00150-4 · Cited by 20 · see citing works
“The Remote Assessment of Disease and Relapse-Major Depressive Disorder (RADAR-MDD) study is a multicenter, prospective observational cohort study and a part of the RADAR-CNS program [126].”
Denyer, H., Deng, Q., Adanijo, A., Asherson, P., Bilbow, A., Folarin, A., Groom, M., Hollis, C., Wykes, T., Dobson, R., et al. (2023) · JMIR Formative Research · doi:10.2196/44126 · Cited by 12 · see citing works
“For research, a remote ADHD assessment and monitoring battery will enable detailed, frequent, long-term, and real-world data collection on the clinical symptoms of ADHD and co-occurring disorders, functional and cognitive impairments, and health behaviors (such as exercise and sleep) in large sample sizes [5,7].”
BackgroundSelf-citationLangholm, C., Kowatsch, T., Bucci, S., Cipriani, A., & Torous, J. B. (2023) · Digital Biomarkers · doi:10.1159/000530698 · Cited by 16 · see citing works
“Other larger digital phenotyping studies have even reported that data quality concerns (related to the amount of sensor data captured vs. expected) preclude any reliable formal analysis [18].”
BackgroundMatcham, F., Carr, E., White, K. M., Leightley, D., Lamers, F., Siddi, S., Annas, P., de Girolamo, G., Haro, J. M., Horsfall, M., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.005 · Cited by 13 · see citing works
“With over 600 individuals participating in the study for a median of 541 days (Matcham et al., 2022), RADAR-MDD provides insights into relationships between clinical presentation, perceptions of technology usability, and long-term engagement in a major depression population.”
Self-citationde Angel, V., Lewis, S., White, K. M., Matcham, F., & Hotopf, M. H. (2022) · JMIR Mental Health · doi:10.2196/38934 · Cited by 15 · see citing works
“Studies examining the severity of depression and device engagement are already underway [37].”
BackgroundSelf-citationPluym, N., Burkhardt, T., Scherer, G., & Scherer, M. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01047-1 · Cited by 14 · see citing works
“With the high availability of smartphones and internet worldwide including in LMICs, app-based QBAs and use recording can facilitate documentation making the data accessible in real time for future studies as demonstrated in other fields [81–83].”
MethodTowards a consensus roadmap for a new diagnostic framework for mental disorders
Kas, M. J., Hyman, S. E., Williams, L. M., Hidalgo‐Mazzei, D., Huys, Q. J. M., Hotopf, M. H., Cuthbert, B. N., Lewis, C. M., Picker, L. D., Lalousis, P. A., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.08.515 · Cited by 13 · see citing works
“The programme identified excellent recruitment and retention, with variable data completeness according to whether data were passively or actively collected, the latter having considerably better completeness (Matcham et al., 2022).”
BackgroundSelf-citationRees, J., Liu, W., Sebastien Ourselin, A., Shi, Y., Probst, F., Antonelli, M., Tinker, A., & Matcham, F. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072420 · Cited by 10 · see citing works
Self-citationEvaluating and mitigating unfairness in multimodal remote mental health assessments
Jiang, Z., Seyedi, S. S., Griner, E. L., Abbasi, A., Rad, A. B., Kwon, H., Cotes, R. O., & Clifford, G. D. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000413 · Cited by 12 · see citing works
“The probability of the presence of seven basic emotions (neutral, happiness, sadness, surprise, fear, disgust, and anger) and 12 facial action units [49] (AU1, 2, 4, 6, 7, 10, 12, 14, 15, 17, 23, 24) was estimated using convolutional neural network (CNN) based models [50, 51].”
MethodJiang, Z., Seyedi, S. S., Griner, E. L., Abbasi, A., Rad, A. B., Kwon, H., Cotes, R. O., & Clifford, G. D. (2023) · medRxiv · doi:10.1101/2023.09.11.23295212 · Cited by 11 · see citing works
“This begs the question of whether data collected re-motely, such as in [49], [50], and in our previous research protocol [19], can provide a similar level of information as the data collected in a lab-controlled environment.”
ResultAssessing seasonal and weather effects on depression and physical activity using mobile health data
Zhang, Y., Folarin, A., Ranjan, Y., Cummins, N., Rashid, Z., Conde, P., Stewart, C., Sun, S., Vairavan, S., Matcham, F., et al. (2025) · npj Mental Health Research · doi:10.1038/s44184-025-00125-x · Cited by 12 · see citing works
“Due to rolling enrollment, the follow-up durationvariedfrom 11monthsto24 months 50 .”
InfluentialSelf-citationSiddi, S., Giné-Vázquez, I., Bailón, R., Matcham, F., Lamers, F., Kontaxis, S., Laporta, E., Pagès, E. G., Arranz, B., Costa, G. D., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237163 · Cited by 9 · see citing works
“For more details on the available data in the MDD cohort, see [64].”
Self-citationLenze, E. J., Torous, J. B., & Areán, P. A. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01664-7 · Cited by 10 · see citing works
Digitale Technologien zur Verbesserung der psychischen Gesundheit
Fuhr, D. C., Wolf‐Ostermann, K., Hoel, V., & Zeeb, H. (2024) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-024-03842-4 · Cited by 12 · see citing works
Stein, M., Stegherr, R., Narayanaswami, P., Legg, D., Herdick, M. L., Meisel, A., Gerischer, L. M., & Lehnerer, S. (2024) · JMIR Formative Research · doi:10.2196/58266 · Cited by 9 · see citing works
Kuehne, C., Phillips, M. D., Moody, S. C., Bryson, C., Campbell, I. C., Conde, P., Cummins, N., Desrivières, S., Dineley, J., Dobson, R., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05841-w · Cited by 8 · see citing works
“The perceived impact of RMT on weight-and food-related behaviours and attitudes was assessed as part of a qualitative interview study with former participants from the RADAR-MDD study who reported an ED diagnosis during their participation [58].”
MethodSelf-citationWright, L. A., Moore, M. R., Reeves, S., Vallejos, E. P., & Morriss, R. K. (2025) · JMIR Formative Research · doi:10.2196/65140 · Cited by 7 · see citing works
“…RADAR platform, as used in depression, multiple sclerosis, and epilepsy, uses passive monitoring to obtain a general detection of important changes in the underlying condition, which then triggers active data completion to provide more granularity and greater sensitivity and specificity [17,25,26].”
Holmqvist, S. L., Kaplan, M., Chaturvedi, R., Shou, H., & Giovannetti, T. (2025) · JMIR Human Factors · doi:10.2196/69952 · Cited by 7 · see citing works
“Adherence to wearable device use, which is relatively less demanding, versus the completion of daily EMA surveys has been estimated to be approximately >90% and 70%, respectively, in studies that are not fully remote [16-19].”
White, K. M., Matcham, F., Leightley, D., Carr, E., Conde, P., Dawe‐Lane, E., Ranjan, Y., Simblett, S. K., Henderson, C., & Hotopf, M. H. (2021) · JMIR Research Protocols · doi:10.2196/32653 · Cited by 7 · see citing works
Self-citationLam, R. W., Rnic, K., Nunez, J.-J., Ho, K., LeMoult, J., Nunes, A., Chakrabarty, T., Foster, J. A., Frey, B. N., Harkness, K. L., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251337603 · Cited by 6 · see citing works
Self-citationBonnechère, B. (2022) · Genes · doi:10.3390/genes14010063 · Cited by 6 · see citing works
“) must be used to assess the quality of the data and evaluate the context in which these data were collected [94,95].”
BackgroundWhite, K. M., Carr, E., Leightley, D., Matcham, F., Conde, P., Ranjan, Y., Simblett, S. K., Dawe‐Lane, E., Williams, L., Henderson, C., et al. (2023) · JMIR mhealth and uhealth · doi:10.2196/44214 · Cited by 7 · see citing works
“This measure was chosen to align with previous data availability reporting [12] and other studies [38].”
InfluentialSelf-citationIncreasing the Value of Digital Phenotyping Through Reducing Missingness: A Retrospective AnalysisPreprint
Currey, D., & Torous, J. B. (2022) · medRxiv · doi:10.1101/2022.05.17.22275182 · Cited by 6 · see citing works
Multilingual markers of depression in remotely collected speech samplesPreprint
Cummins, N., Dineley, J., Conde, P., Matcham, F., Siddi, S., Lamers, F., Carr, E., Lavelle, G., Leightley, D., White, K. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2183980/v1 · Cited by 6 · see citing works
Self-citationBrown, R. D., Bondy, E., Prim, J., Dichter, G. S., & Schiller, C. E. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1448914 · Cited by 6 · see citing works
Khan, H., Aerts, S., Vermeulen, I., Woodruff, H. C., Lambin, P., & Peeters, L. M. (2025) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-025-01748-z · Cited by 5 · see citing works
“To date, AI has already shown promise in improving diagnostic and prognostic performances, workflow, and cost-effectiveness in various fields such as oncology [10], Parkinson’s disease [11], depression [12], and epilepsy [13].”
Wright, L. A., Majid, M., Shajan, G., Momoh, G., Patil, R., Rawsthorne, M., Purewal, D., Patel, S., & Morriss, R. K. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02118-8 · Cited by 5 · see citing works
LINC: a framework for maintaining high-quality passive data in digital phenotyping studies
Calvert, E., Lane, E., Flathers, M., & Torous, J. B. (2026) · Scientific Reports · doi:10.1038/s41598-026-41435-0 · Cited by 5 · see citing works
Oetzmann, C., Cummins, N., Lamers, F., Matcham, F., Siddi, S., White, K. M., Haro, J. M., Vairavan, S., Penninx, B. W. J. H., Narayan, V. A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314604 · Cited by 5 · see citing works
Self-citationGeorgescu, A. L., Cummins, N., Molimpakis, E., Giacomazzi, E., Marczyk, J. R., & Goria, S. (2024) · JMIR Formative Research · doi:10.2196/55856 · Cited by 4 · see citing works
“This approach, as shown in the Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD) study, is characterized by high adherence, making it a practical, accessible, and engaging method for patients [13].”
Self-citationAlt, A. K., Pascher, A., Seizer, L., Finkbeiner, M., Conzelmann, A., & Renner, T. J. (2024) · Internet Interventions · doi:10.1016/j.invent.2024.100785 · Cited by 5 · see citing works
“Information resulting from sensors can also be used to assess the risk of relapse in major depressive disorder (Matcham et al., 2022; Zlatintsi et al., 2022) by using digital questionnaires via smartphone in combination with measuring the patient's activity behavior to determine the risk of relapse.”
Condominas, E., Niubo, A. S., Domènech‐Abella, J., Haro, J. M., Bailón, R., Giné-Vázquez, I., Alacid, G. R., Matcham, F., Lamers, F., Kontaxis, S., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.010 · Cited by 5 · see citing works
“In this self-rated version (IDS-SR26), a cut-off-point ≥ 22 indicates the presence of clinically relevant depressive symptomatology ( ≥ 26 score were considered in the previous papers (Matcham et al., 2022) including the items 1 – 4.”
Self-citationAdelman, M. R., Aalbers, G., Matcham, F., Simblett, S. K., Leightley, D., Siddi, S., Haro, J. M., Oetzmann, C., Narayan, V. A., Hotopf, M. H., et al. (2025) · Depression and Anxiety · doi:10.1155/da/1509978 · Cited by 4 · see citing works
“A full description of the RADAR-MDD sample, recruitment, data availability, and retention rates are available in Matcham et al. [32].”
InfluentialSelf-citationBiomarker Methodologies: A NIMH Perspective
Grabb, M. C., & Brady, L. S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69491-2_1 · Cited by 4 · see citing works
Dobson, R., Zhang, Y., Pratap, A., Folarin, A., Sun, S., Cummins, N., Matcham, F., Vairavan, S., Dineley, J., Ranjan, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1602069/v1 · Cited by 4 · see citing works
Self-citationWright, L. A., Roe, J., Guo, B., & Morriss, R. K. (2026) · JMIR Mental Health · doi:10.2196/83765 · Cited by 3 · see citing works
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision
Furukawa, S., Uchida, H., & Kishimoto, T. (2026) · Pharmacopsychiatry · doi:10.1055/a-2810-8972 · Cited by 6 · see citing works
Collection and Analysis of Repeated Speech Samples: Methodological Framework and Example Protocol
Cummins, N., White, L. L., Rahman, Z., Lucas, C., Pan, T., Carr, E., Matcham, F., Downs, J. M., Dobson, R., Quatieri, T. F., et al. (2025) · JMIR Research Protocols · doi:10.2196/69431 · Cited by 3 · see citing works
“While not 50/50, this is more balanced than the 75/25 female/male balance of the clinical speech cohort recruited in RADAR-MDD, which was attributed to the greater reported incidence of depression in women [7,60].”
Self-citationMental Health and Mobile Communication Profiles of Crowdsourced Participants
Tlachac, M., & Heinz, M. V. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3436654 · Cited by 4 · see citing works
Hamlin, M., Holmén, J., Wentz, E., Aiff, H., Ali, L., & Steingrímsson, S. (2023) · JMIR Mental Health · doi:10.2196/48843 · Cited by 3 · see citing works
“Furthermore, studies have reported that several participants linked a higher severity of depression with reduced adherence to the mobile app [32,33].”
BackgroundBeames, J. R., Dabash, O., Spoelma, M. J., Shvetcov, A., Zheng, W. Y., Slade, A., Han, J., Hoon, L., Kupper, J. F., Parker, R., et al. (2025) · JMIR Formative Research · doi:10.2196/71377 · Cited by 2 · see citing works
Manrai, R., Swiffen, D., Wyse, C. A., Gray, D., Ferguson, A., Lopez, L. M., Campbell, I. H., Murray, A. L., Caddick, L., Gale, E. L., et al. (2025) · Wellcome Open Research · doi:10.12688/wellcomeopenres.23662.1 · Cited by 2 · see citing works
Wright, L. A., Monk-Cunliffe, J., Guo, B., & Morriss, R. K. (2025) · JMIR Mental Health · doi:10.2196/79500 · Cited by 2 · see citing works
“…depression Hidalgo-Mazzei et al [41]; Hidalgo-Mazzei et al [42]; Garcia-Estela et al [43]; Drake et al [51]; Van der Watt et al [46]; Matcham et al [53] Unwelcome reminder of mental illness 2 (8) Bipolar disorder Hidalgo-Mazzei et al [42]; Garcia-Estela et al [43] Difficult to use 3 (12) Bipolar…”
InfluentialSieberts, S. K., Burn, A., Carey, E., Carlson, S., Fernandes, B., Kalha, J., Lindani, S., Marten, C., Neelakantan, L., Ranganathan, S., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19383.1 · Cited by 2 · see citing works
Acceptability of Remote Monitoring Technologies for Early Warning of Major Depression
Haley, F., Andrews, J. A., & Moghaddam, N. G. (2025) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-025-00530-1 · Cited by 2 · see citing works
Braun, M., Crombez, G., Debeer, D., & Paepe, A. L. D. (2025) · Psychology and Health · doi:10.1080/08870446.2025.2582467 · Cited by 1 · see citing works
Kiguchi, R., Hata, A., Fujita, S., Yoshida, Y., Kitanishi, Y., Yoshimoto, J., Tajika, A., & Furukawa, T. A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119703 · Cited by 1 · see citing works
Hammelrath, L., Brose, A., Heinrich, M., Zagorscak, P., Burchert, S., Langhammer, T., & Knaevelsrud, C. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102392 · Cited by 1 · see citing works
“Second, we will use aggregates of EMA assessments on positive and negative affect (PANAS-X; 21) collected during measurement bursts at T20 and TPost as additional indicators of treatment response as EMA-based measures were shown to capture different aspects of symptom load (28).”
A literature review of remote mental health screening: barriers, potential solutions, and tools
Quiram, N., Salam, T., Sadjadpour, F., Hosseinichimeh, N., Jarvis, L. R., & Soghier, L. M. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1670691 · Cited by 1 · see citing works
Stimpson, K. H., Feyder, M. T., Maron‐Katz, A., Kiris, E., Ford, T. J., Carreon, D. M., DeSouza, D. D., Cole, E. J., Meng, N. F., Williams, N., et al. (2025) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2025.100203 · Cited by 1 · see citing works
Ross-Adelman, M., Aalbers, G., Matcham, F., Leightley, D., Oetzmann, C., Carr, E., Siddi, S., Haro, J. M., Annas, P., Dalby, M., et al. (2026) · Neuroscience Applied · doi:10.1016/j.nsa.2026.106985
“This paper presents a secondary analysis of RADAR-MDD, a multi-center longitudinal observational cohort study designed to remotely monitor individuals with recurrent major depressive disorder using smartphones and wearables (Matcham et al., 2019).”
InfluentialSelf-citationWearable Technology for Depression Assessment: A Scoping Review of Datasets
Tlachac, M., Elsbree, H. K., & Heinz, M. V. (2026) · IEEE Transactions on Affective Computing · doi:10.1109/taffc.2026.3704930
“Othertimeframesincludedaily[50],[87],[88],biweekly[84], [116],weekly[77],[84],[92],everytwoweeks[43],[72],[96], [102],[106],[110],[111],[132],monthly[41],everythree months[98],[105],andevery6months[107].”
InfluentialBladon, S., Ainsworth, J. D., Cahuantzi, R., Cella, M., Drake, R., Eisner, E., Emsley, R., Faulkner, S., Greenwood, K., Gumley, A. I., et al. (2026) · JMIR Formative Research · doi:10.2196/86049 · Cited by 1 · see citing works
“We selected commercially available wearables rather than research-grade devices because previous similar studies demonstrated good uptake and adherence with commercial-grade devices during longitudinal monitoring [15,16].”
Self-citationKang, X., Ding, W., Matsumoto, K., Wang, L., Yu, H.-T., & Shi, X. (2026) · Information Fusion · doi:10.1016/j.inffus.2026.104702 · Cited by 1 · see citing works
Ribeiro, T. C., Pagès, E. G., Ballester, L., Vilagut, G., García‐Mieres, H., Aragonès, V. S., Amigo, F., Bailón, R., Mortier, P., Pérez, V., et al. (2024) · JMIR Research Protocols · doi:10.2196/51298 · Cited by 1 · see citing works
“Wearable devices allow researchers to passively monitor individuals in real time and gather data outside of traditional laboratory settings, that is, along with everyday life situations, providing a more holistic understanding of mental health status [25,26].”
BackgroundHaley, F., Andrews, J. A., & Moghaddam, N. G. (2024) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-024-00457-z · Cited by 1 · see citing works
“While this still constitutes only half of the largest sample sizes noted in this review, the extended 2-year follow-up of participants has yielded an extensive repository of sequential time-related data, encompassing demographics from three distinct European nations (Matcham et al., 2022).”
Stein, M., Stegherr, R., Narayanaswami, P., Legg, D., Herdick, M. L., Meisel, A., Gerischer, L. M., & Lehnerer, S. (2024) · doi:10.2196/preprints.58266 · Cited by 1 · see citing works
de Angel, V., Lewis, S., White, K. M., Matcham, F., & Hotopf, M. H. (2022) · doi:10.2196/preprints.38934
Self-citationde Angel, V., Adeleye, F., Zhang, Y., Cummins, N., Munir, S., Lewis, S., Laporta, E., Matcham, F., Sun, S., Dobson, R., et al. (2022) · doi:10.2196/preprints.42866
Self-citationGeorgescu, A. L., Cummins, N., Molimpakis, E., Giacomazzi, E., Marczyk, J. R., & Goria, S. (2024) · doi:10.2196/preprints.55856
Self-citationZhang, Y., Folarin, A., Ranjan, Y., Cummins, N., Rashid, Z., Conde, P., Stewart, C., Sun, S., Vairavan, S., Matcham, F., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4254244/v1
Self-citationAlt, A. K., Pascher, A., Seizer, L., Finkbeiner, M., Conzelmann, A., & Renner, T. J. (2024) · doi:10.2196/preprints.58561
Barajas, B. V. R., Arelis, A. A., Garcı́a‐Estrada, J., & Yepez, J. E. (2024) · Revista de Fomento Social · doi:10.24875/rmn.23000053
“It was also shown that remote evaluation of psychiatric and cognitive alterations was possible, as well as data collection by questionnaires and interviews 48 .”
Ibáñez, D., Condominas, E., Haro, J. M., Giné-Vázquez, I., RADAR-MDD-Spain, Bailón, R., Pagès, E. G., Kontaxis, S., Peñarrubia‐María, M. T., Arranz, B., et al. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1436611
Self-citationBeames, J. R., Dabash, O., Spoelma, M. J., Shvetcov, A., Zheng, W. Y., Slade, A., Han, J., Hoon, L., Kupper, J. F., Parker, R., et al. (2025) · doi:10.2196/preprints.71377
Hammelrath, L., Brose, A., Heinrich, M., Zagorscak, P., Burchert, S., Langhammer, T., & Knaevelsrud, C. (2025) · medRxiv · doi:10.1101/2025.03.14.25323957
“Based on previous studies investigating the feasibility of digital phenotyping in clinical samples (26), it was further expected that 75% of the sample would decide for the long version of the study, resulting in 350 patients providing data at T20 and TPost.”
Amalakanti, S., Avula, V. C. R., & Jillella, J. P. (2025) · Archives of Mental Health · doi:10.4103/amh.amh_35_25
Caruso, A., Vázquez, C. G., Eicher, C., Huber, R., Kronenberg, G., Landolt, H., Seifritz, E., & Poian, G. D. (2025) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc58623.2025.11251685
“Data from devices such as wearable devices, accelerometers, and mobile applications can offer continuous real-time insights into the physiological and social aspects of depression, allowing the detection of nuanced symptom patterns over time [10–12].”
Kuehne, C., Phillips, M. D., Moody, S., Bryson, C., Campbell, I. C., Conde, P., Cummins, N., Desrivières, S., Dineley, J., Dobson, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25940235
Self-citationKuehne, C., Phillips, M. D., Moody, S., Bryson, C., Campbell, I. C., Conde, P., Cummins, N., Desrivières, S., Dineley, J., Dobson, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25940077
Self-citationPluym, N., Burkhardt, T., Scherer, G., & Scherer, M. (2024) · Figshare · doi:10.6084/m9.figshare.26743655
Pluym, N., Burkhardt, T., Scherer, G., & Scherer, M. (2024) · Figshare · doi:10.6084/m9.figshare.26743658
Kuehne, C., Yim, S. H., İnce, B., Fordham, E., Matcham, F., Simblett, S. K., White, K. M., Folarin, A., Sharpe, H., & Schmidt, U. (2025) · doi:10.2196/preprints.86382
Self-citationCOPE-EMBRACE: Coping with stress after encephalitis using real-time assessment
Fifield, K., Thomas, R., Dawe‐Lane, E., Kusosa, R., O'Connor, E., Cummins, N., Pollak, T. A., Wykes, T., Easton, A., & Simblett, S. K. (2026) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2026.2619548
Self-citation
- Authors
- Matcham, F., Leightley, D., Siddi, S., Lamers, F., White, K. M., Annas, P., de Girolamo, G., Difrancesco, S., Haro, J. M., Horsfall, M., Ivan, A., Lavelle, G., Li, Q., Lombardini, F., Mohr, D. C., Narayan, V. A., Oetzmann, C., Penninx, B. W. J. H., Bruce, S., Nica, R., Simblett, S. K., Wykes, T., Brasen, J. C., Myin-Germeys, I., Rintala, A., Conde, P., Dobson, R. J. B., Folarin, A. A., Stewart, C., Ranjan, Y., Rashid, Z., Cummins, N., Manyakov, N. V., Vairavan, S., Hotopf, M., & on behalf of the RADAR-CNS consortium
- Affiliations
- King's College London (GB)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Amsterdam Public Health (NL)
- Lundbeck (Denmark) (DK)
- Northwestern University (US)
- LAB University of Applied Sciences (FI)
- Janssen (Belgium) (BE)
- Corresponding author
- Matcham, Faith
- ORCID
- Matcham, Faith
- Leightley, Daniel
- Siddi, Sara
- Lamers, Femke
- White, Katie M.
- Annas, Peter
- Difrancesco, Sonia
- Haro, Josep Maria
- Horsfall, Melany
- Ivan, Alina
- Lavelle, Grace
- Li, Qingqin
- Lombardini, Federica
- Mohr, David C.
- Narayan, Vaibhav A.
- Oetzmann, Carolin
- Penninx, Brenda W. J. H.
- Nica, Raluca
- Simblett, Sara K.
- Wykes, Til
- Brasen, Jens Christian
- Rintala, Aki
- Conde, Pauline
- Dobson, Richard J. B.
- Folarin, Amos A.
- Stewart, Callum
- Ranjan, Yatharth
- Rashid, Zulqarnain
- Manyakov, Nikolay V.
- Vairavan, Srinivasan
- Hotopf, Matthew
- Venue
- BMC Psychiatry
- Published
- 2022-02-21
- Volume
- 22
- Issue
- 1
- Pages
- 136-136
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC8860359
- OpenAlex
- W4225751944
- Cited by
- 110
- References
- 55
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 35 · 2023: 16 · 2022: 14 · 2021: 1
- FWCI
- 20.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Lirias (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- NHS Blood and Transplant
- South London and Maudsley NHS Foundation Trust
- Wellcome Trust (116074)
- King's College Hospital NHS Foundation Trust
- Scottish Government
- European Federation of Pharmaceutical Industries and Associations (116074)
- UK Research and Innovation
- Alzheimer's Society
- National Institute for Health and Care Research (NF-SI-0515-10102, 116074)
- British Heart Foundation
- Department of Health and Social Care
- King's College London
- University College London
- European Commission (115902, 116074, HORIZON2020)
- Public Health Agency
- ZonMw (73305095003)
- King's Health Partners
- Innovative Medicines Initiative (116074)
- Institut Català de la Salut
- GIESKES-STRIJBIS FONDS
- Chief Scientist Office, Scottish Government Health and Social Care Directorate
- NIHR BioResource
- NIHR Maudsley Biomedical Research Centre
- Medical Research Council (MC_PC_17214)
- Engineering and Physical Sciences Research Council
- Economic and Social Research Council
- Health and Social Care Research and Development Division
- National Institute for Health Research Applied Research Collaboration South London
- Health Data Research UK
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- major depressive disorder, recurrent depression, depression relapse, wearable devices, smartphone sensors, participant recruitment and retention, data completeness, multimodal data collection, passive data collection
- MeSH terms
- Smartphone, Chronic Disease, Major Depressive Disorder, Humans, Prospective Studies, Recurrence, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review